Emergence Delirium Clinical Trial
Official title:
Mitigation of Emergence Agitation Through Implementation of Masimo Bridge Therapy
This is a randomized, prospective, double-blinded (patient and outcome-assessor) trial. Our goal is to assess efficacy of Bridge Therapy (versus sham bridge therapy) to prevent emergence agitation following general anesthesia. Primary Objective: Activation of Bridge Therapy from the time of the pre incision "time out" until 24 hours after admission to the PACU (Post Anesthesia Care Unit) is associated with reduced frequency and intensity of emergence agitation. Secondary Objective: Bridge Therapy activation will also result in a lower incidence of rescue pharmacologic treatment of agitation. Tertiary Objective: Activation of Bridge Therapy during a stable anesthetic state is associated with a reduced Patient State Index as measured on Sedline
Status | Not yet recruiting |
Enrollment | 50 |
Est. completion date | June 2025 |
Est. primary completion date | June 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility | Inclusion Criteria: 1. Age 18-90 2. English Speaking 3. ASA Physical Status between I-IV 4. Undergoing a surgical procedure at HMC 5. Patient answers "yes" to one of the following below: 1. Do you drink 7 or more alcoholic beverages per week? 2. Do you use (smoke or eat) cannabis (or other recreational drugs) on a weekly basis? 3. Have you felt disoriented, aggressive, angry, or delirious after waking up from a previous surgery? 4. Have you been told by a care provider or friend/family member that you woke up from surgery in the past disoriented, confused, or aggressive/angry? 5. Have you been diagnosed with post-traumatic stress disorder (PTSD)? Exclusion Criteria: 1. <18 years old, >90 years old 2. Intubated patients 3. Pregnant by HMC lab test 4. Non-English Speaking 5. Has a cardiac pacemaker 6. Hx of bleeding condition 7. Skin issues where the device would be applied, this includes: Dermatitis, Psoriasis vulgaris, skin breakdown, skin integrity compromised. 8. Plan to use dexmedetomidine as part of the anesthetic technique 9. Plan to use sedline for clinical anesthetic management during operating procedure. 10. Patients with previous history of sensitivity to compound benzoin tincture. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Washington |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Patient State Index | Patient State Index or PSI is a clinically validated measure of the effect of anesthesia and sedation. PSI is measured on a Sedline Sedation Monitor. PSI values range from 0 (total cortical silence) to 100 (awake state), and 25-50 indicates the optimal hypnotic state for surgical anesthesia. | From time of the pre incision "time out" until 24 hours after admission to the PACU (Post-Anesthesia Care Unit) | |
Primary | Emergence agitation | Frequency of emergence agitation following general anesthesia will be collected every 15 minutes in the PACU. Once discharged from the PACU this will be measured every 12 hours. | From time of the pre incision "time out" until 24 hours after admission to the PACU (Post-Anesthesia Care Unit) | |
Primary | Emergence agitation | Intensity of emergence agitation following general anesthesia will be measured by the Riker Sedation Agitation Scale (RSAS). The maximum score is 7, the minimum score is 1.
A high scores means a worse outcome (higher agitation). |
time out" until 24 hours after admission to the PACU (Post-Anesthesia Care Unit) | |
Secondary | Rescue pharmacologic treatment of agitation | Incidence of rescue pharmacologic treatment of agitation following general anesthesia. This will be measured by the number of times rescue pharmacological treatment was given. | From time of the pre incision "time out" until 24 hours after admission to the PACU (Post-Anesthesia Care Unit) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03787849 -
Epigenetics in PostOperative Pediatric Emergence Delirium
|
N/A | |
Completed |
NCT03788564 -
The Association of Cardiac Ion Channel Related Gene Polymorphism and Prolonged QTc Interval After Endotracheal Intubation
|
||
Recruiting |
NCT01221025 -
Effect Study of Parecoxib to Treat Emergence Delirium and Postoperative Pain
|
Phase 4 | |
Not yet recruiting |
NCT06035757 -
The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery
|
Phase 4 | |
Not yet recruiting |
NCT04291820 -
Impact of Anaesthesiology Management on Paediatric Emergence Delirium Incidence
|
N/A | |
Completed |
NCT05124067 -
Effect of Dexmedetomidine on Prevention of Postoperative Nausea and Vomiting in Children
|
Phase 1 | |
Recruiting |
NCT05091242 -
The PREVENT AGITATION Trial II - Children ≤1 Year
|
Phase 2/Phase 3 | |
Completed |
NCT03330236 -
EEG - Guided Anesthetic Care and Postoperative Delirium
|
N/A | |
Completed |
NCT04531020 -
Incidence of Emergence Delirium in the PACU
|
||
Completed |
NCT05105178 -
Verbal Stimulation of Orientation on Emergence Agitation
|
N/A | |
Completed |
NCT03285243 -
Effect of Monochromatic Light on Incidence of Emergence Delirium in Children
|
N/A | |
Recruiting |
NCT04621305 -
Remimazolam Reduces Emergence Delirium in Preschool Children Undergoing Laparoscopic Surgery by Sevoflurane Anesthesia
|
Phase 4 | |
Completed |
NCT01096797 -
Correlation Between Pain and Emergence Delirium After Adenotonsillectomy in Preschool Children
|
Phase 4 | |
Recruiting |
NCT03330613 -
Emergence Delirium and Recovery Time in Children
|
N/A | |
Completed |
NCT05872087 -
Comparative Study Between Nebulised Dexmedetomidine and Nebulised Midazolam in Children Undergoing Lower Abdominal Surgeries
|
Phase 1 | |
Recruiting |
NCT06326983 -
Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery
|
N/A | |
Not yet recruiting |
NCT06406257 -
Temperature Management on Postoperative Delirium
|
N/A | |
Not yet recruiting |
NCT05883280 -
The Effect of Binaural Sound on the Occurrence of Emergence Delirium in Children Undergoing Strabismus Surgery
|
N/A | |
Not yet recruiting |
NCT05821972 -
Nebulized Dexmedetomidine Combined With Ketamine Versus Nebulized Dexmedetomidine for Cleft Palate
|
Phase 4 | |
Completed |
NCT03131375 -
Dexmedetomidine Reduces Emergence Delirium in Children Undergoing Tonsillectomy With Propofol Anesthesia
|
Phase 2/Phase 3 |